Tailoring combinatorial cancer therapies to target the origins of adaptive resistance.
Ontology highlight
ABSTRACT: The development of resistance to chemotherapy is a critical yet poorly understood phenomenon driving cancer-related deaths. We recently reported a study that explored the origins of adaptive chemotherapy resistance. During this investigation we unexpectedly discovered that inherent vulnerabilities were unmasked, creating temporal targets for rational combinations of established drugs.
SUBMITTER: Goldman A
PROVIDER: S-EPMC4845182 | biostudies-other | 2016 Jan
REPOSITORIES: biostudies-other
ACCESS DATA